PharmaEssentia - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsPharmaEssentia

PharmaEssentia

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Besremi	Ropeginterferon alfa-2b	2021-11-12		Polycythemia vera

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

urinary bladder neoplasms

,

,

glandular and epithelial neoplasms

,

,

,

,

,

neoplasms by histologic type

,

urinary bladder diseases

,

hodgkin disease

,

myelodysplastic syndromes

,

myeloid leukemia acute

,

,

pancreatic neoplasms

,

,

colorectal neoplasms

,

,

small cell lung carcinoma

,

,

,

,

hepatocellular carcinoma

,

cutaneous malignant melanoma

,

prostatic neoplasms

,

,

transitional cell carcinoma

,

liver neoplasms

,

pancreatic ductal carcinoma

,

colonic neoplasms

,

urologic neoplasms

,

endometrial neoplasms

,

neoplasms by site

,

stomach neoplasms

,

,

female genital neoplasms

,

,

cholangiocarcinoma

,

,

rectal neoplasms

,

kidney neoplasms

,

follicular lymphoma

,

squamous cell neoplasms

,

multiple myeloma

,

plasma cell neoplasms

,

endometrioid carcinoma

,

biliary tract neoplasms

,

neuroendocrine tumors

,

adenocarcinoma of lung

,

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

t-cell lymphoma

,

t-cell lymphoma peripheral

,

oropharyngeal neoplasms

,

prostatic diseases

,

diffuse intrinsic pontine glioma

,

hematologic neoplasms

,

uterine cervical neoplasms

,

bile duct neoplasms

,

genetic therapy

,

serous cystadenocarcinoma

,

smoldering multiple myeloma

,

,

mullerian mixed tumor

,

urogenital neoplasms

,

small cell carcinoma

,

neuroendocrine carcinoma

,

penile neoplasms

,

adrenocortical carcinoma

,

gastrointestinal neoplasms

,

,

drug-related side effects and adverse reactions

,

mouth neoplasms

,

basal cell carcinoma

,

basal cell neoplasms

,

bronchopulmonary dysplasia

,

tobacco smoking

,

b-cell lymphoma marginal zone

,

mantle-cell lymphoma

,

waldenstrom macroglobulinemia

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

burkitt lymphoma

,

oligodendroglioma

,

merkel cell carcinoma

,

hereditary nonpolyposis colorectal neoplasms

,

,

,

non-hodgkin lymphoma

,

microsatellite instability

,

,

non-small-cell lung carcinoma

,

,

,

renal cell carcinoma

,

squamous cell carcinoma of head and neck

,

neoplasm metastasis

,

breast neoplasms

,

squamous cell carcinoma

,

head and neck neoplasms

,

brain neoplasms

,

triple negative breast neoplasms

,

ovarian neoplasms

,

fallopian tube neoplasms

,

ovarian epithelial carcinoma

insulin resistance

,

autoimmune diseases of the nervous system

,

,

nervous system malformations

,

kidney diseases

,

,

,

chronic hepatitis d

,

,

herpesviridae infections

,

,

patient acceptance of health care

,

multiple sclerosis

,

,

relapsing-remitting multiple sclerosis

,

,

drug-related side effects and adverse reactions

,

leukoencephalopathies

,

progressive multifocal leukoencephalopathy

,

hepatitis b virus

,

,

,

,

treatment adherence and compliance

,

,

hepatocellular carcinoma

,

liver neoplasms

,

,

,

,

,

,

chronic hepatitis b

,

,

acquired immunodeficiency syndrome

,

chronic hepatitis

,

,

communicable diseases

,

immunologic deficiency syndromes

,

,

,

medication adherence

,

,

substance-related disorders

,

,

healthy volunteers/patients

,

,

chronic renal insufficiency

,

renal insufficiency

,

,

persistent infection

,

cognitive dysfunction

,

chronic hepatitis c

,

patient compliance

,

,

metabolic diseases

,

,

,

kidney transplantation

,

non-hodgkin lymphoma

,

burkitt lymphoma

,

,

,

neurocognitive disorders

,

sleep wake disorders

,

,

,

anxiety disorders

,

opioid-related disorders

,

metabolic bone diseases

,

,

morphine dependence

,

,

,

,

recreational drug use

,

hiv seropositivity

,

,

liver cirrhosis

,

,

biliary liver cirrhosis

,

,

cardiovascular diseases

,

retinal diseases

,

metabolic syndrome

,

drug interactions

Albinterferon alfa-2b

chronic hepatitis b

,

chronic hepatitis

,

,

chronic hepatitis c

,

,

,

kidney transplantation

communicable diseases

,

,

,

herpesviridae infections

,

,

,

,

chronic hepatitis c

,

,

,

,

,

chronic hepatitis b

,

chronic hepatitis

,

hepatocellular carcinoma

,

liver neoplasms

,

acquired immunodeficiency syndrome

,

liver cirrhosis

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use